The shares of The Medicines Company (NASDAQ:MDCO) started off the last trading session with the price of $32.9 while closing the day with the price of $33.94. The shares of The Medicines Company (NASDAQ:MDCO) Rise 2.01% with the Gain of 1.04 points.
The shares of The Medicines Company (NASDAQ:MDCO) traded with the day volume of 1.23 Million shares whereas its average trading volume is 1.49 Million.
While analyzing the past performance of the stock we can see that the shares of The Medicines Company (NASDAQ:MDCO) Gain 9.24% in the last week while rising 2.44% in the last month. Past quarter performance shows the green light with 12.5%. The semi-annual and annual performance shows -6.84% and -34.79% respectively.
Some critical values of the shares of The Medicines Company (NASDAQ:MDCO) to be discussed here are: the beta which shows the value at 0.67 while Average True Range of The Medicines Company (NASDAQ:MDCO) demonstrate the value at 1.91. The weekly and monthly volatility of the shares of The Medicines Company (NASDAQ:MDCO) are indicated at 6.07% and 6.00%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 60.71.
While studying the financial position of the shares of The Medicines Company (NASDAQ:MDCO), we can see that the Market capitalization of the company is at 2.43 Billion. The shares outstanding for the company is 71.46 Million and the shares float stands at 70.4 Million. The income of the company stand at -689500000 while the sales stand at 68.4 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -9.57, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 35.46, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at -0.171.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) started its previous trading session at $6.13 and closed at $6.66 showing a Rise of 6.05 Percent.
The Company traded with an average Volume of 1.8 Million whereas, its Day Volume stood at 1.23 Million.
Looking at the performance of the stock, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Gain 14.83% in the last week in its shares price and 7.77% in the last month. Quarterly performance shows a green of 88.14 Percent while Semi-Annual and Annual performances shows a 143.07 and 196 percent respectively.
Beta for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands at 2.47 while the ATR (average true range) is at 0.44. The Stock’s Weekly and Monthly Volatility is 8.50% and 8.14% respectively showing a RSI value of 66.2.
While studying the financial position of the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), we can see that the Market capitalization of the company is at 544.99 Million. The shares outstanding for the company is 81.83 Million and the shares float stands at 79.15 Million.
The Company generated an income of -35500000 and the sales of 30.6 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.48 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 17.81 respectively.
The Return on Assets stands at -0.327, ROE shows a value of -0.422 and ROI for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is -0.441 as of Trailing Twelve Months period.
